Form 8-K - Current report:
SEC Accession No. 0000914475-24-000210
Filing Date
2024-10-30
Accepted
2024-10-30 07:02:54
Documents
15
Period of Report
2024-10-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nbix-20241030.htm   iXBRL 8-K 23371
2 EX-99.1 q3-2024xearningsrelease.htm EX-99.1 222220
6 GRAPHIC nbix-20241030_g1.jpg GRAPHIC 18386
  Complete submission text file 0000914475-24-000210.txt   436421

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nbix-20241030.xsd EX-101.SCH 1791
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nbix-20241030_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nbix-20241030_pre.xml EX-101.PRE 12514
17 EXTRACTED XBRL INSTANCE DOCUMENT nbix-20241030_htm.xml XML 2717
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 6027 EDGEWOOD BEND COURT SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22705 | Film No.: 241407412
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)